Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Brian Irving Carr

Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility

Cancers

Cancer Research

Oncology

2019

English

Modulation of Regorafenib Effects on HCC Cell Lines by Epidermal Growth Factor

Cancer Chemotherapy and Pharmacology

English

Related publications

SL1122-37, a Novel Derivative of Sorafenib, Has Greater Effects Than Sorafenib on the Inhibition of Human Hepatocellular Carcinoma (HCC) Growth and Prevention of Angiogenesis

English

Combination of Celecoxib and PD184161 Exerts Synergistic Inhibitory Effects on Gallbladder Cancer Cell Proliferation

English

Interleukin-27 Augments the Inhibitory Effects of Sorafenib on Bladder Cancer Cells

Brazilian Journal of Medical and Biological Research

English

The Effects of Cell Compressibility, Motility and Contact Inhibition on the Growth of Tumor Cell Clusters Using the Cellular Potts Model

Journal of Theoretical Biology

English

Perifosine and Sorafenib Combination Induces Mitochondrial Cell Death and Antitumor Effects in NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts

English

Combination Treatment of Gemcitabine and Sorafenib Exerts a Synergistic Inhibitory Effect on Non‑small Cell Lung Cancer In�vitro and In�vivo via the Epithelial‑to‑mesenchymal Transition Process

English

Key Effects of Confinement on Cell Motility

Biophysical Journal

Biophysics

2015

English

Effects of Taurine on the Motility and Intracellular Free Ca2+ Concentration of Fowl Spermatozoa in Vitro

Reproductive Medicine

Obstetrics

Embryology

1998

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Brian Irving Carr

Ramucirumab and GSK1838705A Enhance the Inhibitory Effects of Low Concentration Sorafenib and Regorafenib Combination on HCC Cell Growth and Motility

Modulation of Regorafenib Effects on HCC Cell Lines by Epidermal Growth Factor

Related publications

SL1122-37, a Novel Derivative of Sorafenib, Has Greater Effects Than Sorafenib on the Inhibition of Human Hepatocellular Carcinoma (HCC) Growth and Prevention of Angiogenesis

Combination of Celecoxib and PD184161 Exerts Synergistic Inhibitory Effects on Gallbladder Cancer Cell Proliferation

Interleukin-27 Augments the Inhibitory Effects of Sorafenib on Bladder Cancer Cells

The Effects of Cell Compressibility, Motility and Contact Inhibition on the Growth of Tumor Cell Clusters Using the Cellular Potts Model

Perifosine and Sorafenib Combination Induces Mitochondrial Cell Death and Antitumor Effects in NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts

Combination Treatment of Gemcitabine and Sorafenib Exerts a Synergistic Inhibitory Effect on Non‑small Cell Lung Cancer In�vitro and In�vivo via the Epithelial‑to‑mesenchymal Transition Process

Key Effects of Confinement on Cell Motility

Effects of Taurine on the Motility and Intracellular Free Ca2+ Concentration of Fowl Spermatozoa in Vitro